Skip to main content
. 2024 Aug 21;14:1412051. doi: 10.3389/fonc.2024.1412051

Table 7.

Treatment-related adverse events.

Toxicity Nab-paclitaxel
(n=166)
Docetaxel (n=59) χ2 P
Diarrhea
0 79 29 0.825 0.662
1~2 73 23
3~4 14 7
Neutropenia
0 92 34 0.454 0.797
1~2 55 17
3~4 19 8
Vomit
0 86 26 1.065 0.587
1~2 67 28
3~4 13 5
Fatigue
0 52 24 3.739 0.154
1~2 80 29
3~4 34 6
Dizziness
0 118 50 5.323 0.070
1~2 41 9
3~4 7 0
Hectic fever
0 113 44 3.154 0.207
1~2 45 15
3~4 8 0
Infusion-related reaction
0 154 54 2.442 0.295
1~2 9 5
3~4 3 0
Decreased appetite
0 101 41 1.511 0.470
1~2 53 14
3~4 12 4
Elevated AST
0 123 43 5.927 0.052
1~2 23 14
3~4 20 2
Elevated ALT
0 127 35 7.762 0.021
1~2 26 19
3~4 13 5
Anemia
0 136 43 2.730 0.255
1~2 25 12
3~4 5 4
Allergy
0 113 18 44.142 0.000
1~2 48 33
3~4 5 8
Peripheral sensory neuropathy
0 69 36 6.713 0.035
1~2 75 17
3~4 22 6
Oral mucositis
0 92 30 4.190 0.123
1~2 50 25
3~4 24 4
Insomnia
0 120 54 9.648 0.008
1~2 29 2
3~4 17 3
Difculty breathing
0 144 51 4.729 0.094
1~2 13 8
3~4 9 0